Showing results (321-330 of 542) with videos related to
Sort By:
Pageof 55
Clinical Colorectal Cancer|November 14, 2017
Treatment and Survival Outcome of BRAF-Mutated Metastatic Colorectal Cancer: A Retrospective Matched Case-Control StudyHamzeh Kayhanian, Emily Goode, Francesco Sclafani, et al.JAMA Oncology|December 6, 2016
Effect of Fluorouracil, Leucovorin, and Oxaliplatin With or Without Onartuzumab in HER2-Negative, MET-Positive Gastroesophageal Adenocarcinoma: The METGastric Randomized Clinical TrialManish A Shah, Yung-Jue Bang, Florian Lordick, et al.Health Technology Assessment (Winchester, England)|February 4, 2014
The clinical effectiveness and cost-effectiveness of ablative therapies in the management of liver metastases: systematic review and economic evaluationEmma Loveman, Jeremy Jones, Andrew J Clegg, et al.Expert Review of Anticancer Therapy|April 27, 2013
Current opinion on optimal treatment for colorectal cancerTimothy J Price, Eva Segelov, Matthew Burge, et al.Histopathology|February 22, 2018
Prognostic value of pathological lymph node status and primary tumour regression grading following neoadjuvant chemotherapy - results from the MRC OE02 oesophageal cancer trialNasser Davarzani, Gordon G A Hutchins, Nicholas P West, et al.Journal of Interventional Cardiology|December 31, 2013
Do outcomes from transcatheter aortic valve implantation vary according to access route and valve type? The UK TAVI RegistryDaniel J Blackman, Paul D Baxter, Chris P Gale, et al.Pancreas|December 20, 2019
Liposomal Irinotecan + 5-FU/LV in Metastatic Pancreatic Cancer: Subgroup Analyses of Patient, Tumor, and Previous Treatment Characteristics in the Pivotal NAPOLI-1 TrialTeresa Macarulla Mercadé, Li-Tzong Chen, Chung-Pin Li, et al.Rare Tumors|January 26, 2023
PARP inhibition utilized in combination therapy with Olaparib-Temozolomide to achieve disease stabilization in a rare case of BRCA1-mutant, metastatic myxopapillary ependymomaPreethika Mahalingam, Sam Smith, Juanita Lopez, et al.Journal of the National Cancer Institute|June 25, 2014
TP53 mutational status and cetuximab benefit in rectal cancer: 5-year results of the EXPERT-C trialFrancesco Sclafani, David Gonzalez, David Cunningham, et al.World Journal of Surgery|March 10, 2022
Impact of the COVID-19 Pandemic on Pediatric Surgical Volume in Four Low- and Middle-Income Country Hospitals: Insights from an Interrupted Time Series AnalysisPaul Park, Ruth Laverde, Greg Klazura, et al.Pageof 55